Chicago-area deals have outpaced the national average but remain below year-ago levels. Next year is expected to be better.

The James Hardie Industries Plc (ASX: JHX) share price has been on the slide for much of the past year, but according to the team at Macquarie, that's creating a significant buying opportunity. The ...

NEW YORK/LONDON, Nov 8 (Reuters) - U.S. drugmaker Pfizer has (PFE.N), opens new tab clinched a $10 billion deal for obesity drug developer Metsera (MTSR.O), opens new tab, capping a fierce biotech ...

Pfizer wins $10 billion bid for Metsera, securing entry into the booming obesity drug market. Novo Nordisk withdraws over US antitrust risks after a heated bidding war. Deal gives Pfizer new momentum ...